Classification of Lymphomas and Hematological Neoplasia in the Era of Genomic Research A Themed Issue in Honor of Dr. Elaine S. Jaffe
This Special Issue contains review articles focusing on several lymphoma entities included in the current WHO classification. The aim of the book is to guide the readers in understanding the evolution of lymphoma classification. The clinicopathological entities described in this issue have been anal...
Saved in:
| Other Authors: | , |
|---|---|
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2022
|
| Subjects: | |
| Online Access: | DOAB: download the publication DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_94513 | ||
| 005 | 20221206 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20221206s2022 xx |||||o ||| 0|eng d | ||
| 020 | |a books978-3-0365-5744-1 | ||
| 020 | |a 9783036557434 | ||
| 020 | |a 9783036557441 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.3390/books978-3-0365-5744-1 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a M |2 bicssc | |
| 100 | 1 | |a Nicolae, Alina |4 edt | |
| 700 | 1 | |a Carbone, Antonino |4 edt | |
| 700 | 1 | |a Nicolae, Alina |4 oth | |
| 700 | 1 | |a Carbone, Antonino |4 oth | |
| 245 | 1 | 0 | |a Classification of Lymphomas and Hematological Neoplasia in the Era of Genomic Research |b A Themed Issue in Honor of Dr. Elaine S. Jaffe |
| 260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2022 | ||
| 300 | |a 1 electronic resource (252 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a This Special Issue contains review articles focusing on several lymphoma entities included in the current WHO classification. The aim of the book is to guide the readers in understanding the evolution of lymphoma classification. The clinicopathological entities described in this issue have been analyzed through the molecular mechanisms involved in their pathogenesis. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Medicine |2 bicssc | |
| 653 | |a lymphomas in PLWH | ||
| 653 | |a KSHV/HHV8 | ||
| 653 | |a EBV | ||
| 653 | |a lymphoma classification | ||
| 653 | |a management | ||
| 653 | |a cART | ||
| 653 | |a HLX | ||
| 653 | |a HOXB9 | ||
| 653 | |a NFIB | ||
| 653 | |a PBX1 | ||
| 653 | |a STAT3 | ||
| 653 | |a TLX2 | ||
| 653 | |a autoimmune hemolytic anemia | ||
| 653 | |a cold agglutinin | ||
| 653 | |a B-cell lymphoproliferative disorder | ||
| 653 | |a lymphomagenesis | ||
| 653 | |a methylation | ||
| 653 | |a histone modification | ||
| 653 | |a indolent | ||
| 653 | |a T-cell | ||
| 653 | |a NK-cell | ||
| 653 | |a lymphoproliferative disorder | ||
| 653 | |a gastrointestinal tract | ||
| 653 | |a genetics | ||
| 653 | |a cell of origin | ||
| 653 | |a T follicular helper cells | ||
| 653 | |a TFH lymphoma | ||
| 653 | |a angioimmunoblastic T-cell lymphoma | ||
| 653 | |a follicular T-cell lymphoma | ||
| 653 | |a peripheral T-cell lymphoma of T-follicular helper immunophenotype | ||
| 653 | |a peripheral T-cell lymphoma | ||
| 653 | |a primary cutaneous B-cell lymphoma | ||
| 653 | |a primary cutaneous marginal zone B-cell lymphoma | ||
| 653 | |a primary cutaneous follicle centre lymphoma | ||
| 653 | |a primary cutaneous diffuse large B-cell lymphoma, leg-type | ||
| 653 | |a primary cutaneous diffuse large B-cell lymphoma, not otherwise specified | ||
| 653 | |a intravascular B-cell lymphoma | ||
| 653 | |a EBV+ mucocutaneous ulcer | ||
| 653 | |a Burkitt lymphoma | ||
| 653 | |a epidemiology | ||
| 653 | |a Plasmodium falciparum | ||
| 653 | |a Epstein Barr virus | ||
| 653 | |a registry studies | ||
| 653 | |a multimodal cancer | ||
| 653 | |a non-Hodgkin lymphoma | ||
| 653 | |a HIV/AIDS | ||
| 653 | |a follicular lymphoma | ||
| 653 | |a in situ follicular neoplasia | ||
| 653 | |a FL transformation | ||
| 653 | |a FL in young patients | ||
| 653 | |a diffuse large B-cell lymphoma NOS | ||
| 653 | |a high grade B-cell lymphoma | ||
| 653 | |a lymphoma | ||
| 653 | |a gene expression profiling | ||
| 653 | |a tumor microenvironment | ||
| 653 | |a diagnostics | ||
| 653 | |a centrocytic lymphoma | ||
| 653 | |a intermediate lymphocytic lymphoma | ||
| 653 | |a Jaffe | ||
| 653 | |a mantle cell lymphoma | ||
| 653 | |a mantle zone lymphoma | ||
| 653 | |a cyclin D1 | ||
| 653 | |a lymphomas | ||
| 653 | |a people living with HIV | ||
| 653 | |a tumor prevention in people living with HIV | ||
| 653 | |a KSHV | ||
| 653 | |a BCL2 rearrangement | ||
| 653 | |a genetic alterations | ||
| 653 | |a histological transformation | ||
| 653 | |a targeted therapies | ||
| 653 | |a transformed follicular lymphoma | ||
| 653 | |a lymphoproliferative neoplasms of uncertain biological significance | ||
| 653 | |a monoclonal B-cell lymphocytosis | ||
| 653 | |a "in situ" follicular neoplasia | ||
| 653 | |a "in situ" mantle cell neoplasia | ||
| 653 | |a atypical germinal centers | ||
| 653 | |a large B-cell lymphoma with IRF4 rearrangement | ||
| 653 | |a "in situ" high-grade B lymphomas | ||
| 653 | |a Hodgkin lymphoma | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/6345 |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/94513 |7 0 |z DOAB: description of the publication |